CAS 160003-66-7: Iniparib
Formula:C7H5IN2O3
InChI:InChI=1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11)
InChI key:InChIKey=MDOJTZQKHMAPBK-UHFFFAOYSA-N
SMILES:N(=O)(=O)C1=CC(C(N)=O)=CC=C1I
Synonyms:- AntiPARP-2
- Benzamide, 4-iodo-3-nitro-
- Bsi 201
- Iniparib
- Ino2Ba
- Niba
- Sar240550
- Sml 0623
- 4-Iodo-3-nitrobenzamide
Sort by
Found 7 products.
Iniparib
CAS:Iniparib (BSI-201) (BSI-201) , a PARP1 inhibitor, exhibits potency in triple-negative breast Y (TNBC).Formula:C7H5IN2O3Purity:98.93%Color and Shape:SolidMolecular weight:292.03Ref: TM-T6224
5mg50.00€10mg77.00€25mg126.00€50mg229.00€100mg359.00€200mg570.00€500mg912.00€1mL*10mM (DMSO)55.00€Benzamide, 4-iodo-3-nitro-
CAS:Formula:C7H5IN2O3Purity:97%Color and Shape:SolidMolecular weight:292.03074-Iodo-3-nitrobenzamide
CAS:Iniparib is a cancer drug that belongs to the class of platinum-based chemotherapy drugs. It inhibits the activity of pro-apoptotic proteins and is used to treat ovarian cancer with low potency. Iniparib has been shown to inhibit the growth of breast cancer cells, as well as other types of cancers. The drug also has an inhibiting effect on metabolic disorders, such as obesity and diabetes, which may be linked to its homologous properties. Iniparib may be useful in treating certain cancers because it has minimal toxicity levels and a low potential for systemic side effects that are common with other chemotherapeutic agents.END>Formula:C7H5IN2O3Purity:Min. 95%Molecular weight:292.03 g/molRef: 3D-FI140420
Discontinued productIniparib
CAS:Formula:C7H5IN2O3Purity:>98.0%(GC)Color and Shape:White to Yellow powder to crystalMolecular weight:292.03
